- Home
- Articles
- latamerica
- clinical validation
Refine by
Clinical Validation Articles & Analysis
52 articles found
Why Routine Inspection, Cleaning/Disinfection, Manufacturer Checkups, and Backup Systems Matter Summary Dental and surgical loupes are not just magnification devices; they are clinical tools that impact infection control, visual performance, precision, and clinician posture. As a wearable device used in patient care environments, dental and surgical loupes are exposed to aerosols, spatters, ...
This approach has gained rapid attention across academia, biotech, and big pharma. Clinical Progress Preceding Academic Validation Interestingly, clinical development in in vivo CAR-T advanced before large-scale academic confirmation was published. ...
As the end of the year approaches, many clinicians look for smart ways to invest in their practice while reducing taxable income. One powerful opportunity often overlooked is the Section 179 tax deduction — a U.S. tax incentive that allows businesses, including dental and medical practices, to deduct the full purchase price of qualifying equipment in the year it is placed in service. If ...
Brain tumors represent a significant oncology challenge due to their complex genetic profiles and diverse clinical manifestations. To date, scientists have leveraged various therapeutic avenues, including precision medicine, targeted therapies, and immunotherapy. ...
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. However, the success and general applicability of these treatments heavily depend on the diversity of the participants involved¹?³. This blog explores the importance of achieving data diversity in clinical trials to enhance clinical trial results and ...
By targeting specific pathways critical to the growth and survival of the excretory system, the scientists aim to develop more effective and less toxic treatments for brain excretory mechanisms. At the same time, pre-clinical studies are also significant to assess the efficacy and safety of small molecule drugs in brain cancer before they enter clinical trials ...
POCT (Point-of-Care Testing) refers to clinical and bedside testing conducted in close proximity to patients. It is often not performed by clinical laboratory personnel. POCT holds significant importance in disease prevention, etiology determination, prognosis, enhancing treatment outcomes, and reducing healthcare expenses. It meets clinical testing needs across various healthcare settings. POCT ...
People living with frontotemporal dementia, or FTD, are commonly misdiagnosed with psychiatric disorders or Alzheimer’s disease and other causes of dementia, such as Parkinson’s disease and vascular dementia. While frontotemporal dementia and Alzheimer’s disease can both cause dementia, there are distinct differences in impacted regions of the brain and, consequently, ...
December 2022 edition Given the regular posts of peer-reviewed scientific publications on the Medis QFR®, it is clear that this angio-based solution for coronary physiology is extensively used in clinical research and practice. We would like to share these publications with you so that you remain up to date about the research that is ongoing worldwide with this ...
At the turn of the last century, researchers ran clinical trials and validation studies on drugs that were already being used. ...
From clinical trial enrollment through completion, understanding medication adherence is critical to data integrity and AiCure offers a competitive edge where traditional methods fall short. To ensure trial participants are complying with dosing regimens, sites often rely on traditional patient reported outcome systems with participant diaries, which can be unreliable. Also in common use are ...
ByAiCure
The ClarityDX Prostate® test uses a proprietary machine-learning algorithm that combines data from biological and clinical biomarkers to generate a risk score for clinically significant prostate cancer, defined as Gleason grade group 2 or higher, on prostate biopsy. ...
EDMONTON, AB, June 30, 2022 /CNW/ - Nanostics Inc., a precision health diagnostics company, today announces positive data from a pre-biopsy clinical validation study of its ClarityDX Prostate® test designed to improve the accuracy of detecting clinically significant prostate cancer in men that are at risk of the disease. The ClarityDX ...
Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. ...
Meditation is often thought of as an avenue to clarity and self-awareness, but it may also be an avenue to better brain health. Emerging research suggests meditation may have significant benefits to brain health, ranging from improved mental and behavioral health to enhanced cognitive function. In this article, we will break down how meditation helps the brain and provide helpful tips for ...
Many neurological diseases, including Alzheimer’s disease, can be thought of as continuums, whether the presence and manifestation of the disease are different depending on the stage of the disease. In this article, we provide a high-level overview of the stages in the Alzheimer's disease continuum, with a focus on preclinical Alzheimer’s disease and its importance in patient care and ...
“Our acceptance into the Medtech Accelerator program is tremendously validating for the progress we have made to date. It demonstrates the excitement among clinicians and the investment community about the Orchid SRV and our approach to solving a widely recognized problem in nursing and vascular access care. ...
In addition to the pandemic, the digitization of healthcare is rapidly shifting clinical trials from analog to hybrid or fully decentralized clinical trials, catalyzing the development and implementation of digital health technologies to support clinical research. Digital endpoints not only support the decentralization of clinical trials but also provide a means to collect more sensitive, ...
Alzheimer’s and Parkinson’s disease are both neurological diseases that cause progressive damage to the brain, resulting in a decline in neurocognitive function. While Parkinson’s disease is known for affecting movement and function and Alzheimer’s disease is known for affecting cognition, they are a bit more complex than that. Below, we provide an overview of ...
In recent years, targeted protein degraders have entered the mainstream of drug development at a very rapid rate. Thalidomide and its derivatives for the treatment of multiple myeloma and other conditions have demonstrated the potential of protein degraders, while ARV-471, an estrogen receptor degrader based on the drug development of thalidomide, is targeted at the early stage of breast cancer ...